A Peptide-Based PD1 Antagonist Enhances T-Cell Priming and Efficacy of a Prophylactic Malaria Vaccine and Promotes Survival in a Lethal Malaria Model.
Front Immunol
; 11: 1377, 2020.
Article
in En
| MEDLINE
| ID: mdl-32733457
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Lymphocyte Activation
/
Malaria Vaccines
/
Programmed Cell Death 1 Receptor
/
Malaria
Limits:
Animals
Language:
En
Journal:
Front Immunol
Year:
2020
Type:
Article
Affiliation country:
United States